Clinical Trial: A Clinical Trial of AK152 in Healthy Volunteers and Patients With Alzheimer' s Disease

U.S., Dec. 25 -- ClinicalTrials.gov registry received information related to the study (NCT07301502) titled 'A Clinical Trial of AK152 in Healthy Volunteers and Patients With Alzheimer' s Disease' on Dec. 01.

Brief Summary: This is a randomized, double-blind phase I clinical trial to evaluate the Safety, Tolerability, Pharmacokinetics, Immunogenicity, and Preliminary Efficacy of AK152 in Healthy Volunteers and Patients with Alzheimer' s Disease.

Study Start Date: Dec., 2025

Study Type: INTERVENTIONAL

Condition: Alzheimer' s Disease

Intervention: DRUG: AK152

Subjects receiving single or multiple doses of AK152 injection.

DRUG: Placebo

Subjects receiving single or multiple doses of placebo injection.

Recruitment Status: NOT_YET_REC...